A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE

被引：7
|
作者：
Descamps, Olivier S. [1 ,2 ]
Cooney, Marie Therese [3 ]
De Backer, Guy [4 ]
Graham, Ian [3 ]
机构：
[1] Hop Jolimont, Ctr Rech Med Jolimont, B-7100 Haine St Paul, Belgium
[2] Hop Jolimont, Dept Med Interne, B-7100 Haine St Paul, Belgium
[3] Adelaide & Meath Hosp, Dept Cardiol, Dublin 24, Ireland
[4] Ghent Univ Hosp, Dept Cardiol, Ghent, Belgium
来源：
ATHEROSCLEROSIS | 2012年 / 222卷 / 02期
关键词：
SCORE; Cardiovascular risk; Risk assessment; Prevention; HDL cholesterol; Guidelines; GUIDELINES; DISEASE;
D O I：
10.1016/j.atherosclerosis.2012.03.035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The 2011 ESC-EAS guidelines on the management of dyslipidaemias use four separate charts to illustrate the impact of differing HDL cholesterol levels on risk of cardiovascular disease. We developed an easy way to calculate the effects of differing HDL-C levels on risk by deriving HDL and sex specific multipliers and applying these to various reference charts. Of three strategies explored, one based on a low HDL (0.8 mmol/l) reference chart was the simplest and was acceptably accurate. Such an approach simplifies risk estimation by avoiding the need for multiple charts. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：564 / 566
页数：3
相关论文
共 50 条
  • [41] Effect of historical changes in HDL-cholesterol measurements on cardiovascular risk assessment
    Marrington, R.
    Webster, C.
    Jewkes, C.
    Jones, A.
    ATHEROSCLEROSIS, 2011, 218 (02) : E2 - E2
  • [42] HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target
    Bhatt, Anish
    Rohatgi, Anand
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (01) : 1 - 8
  • [43] A simple risk score using routine data for predicting cardiovascular disease in primary care
    Chamnan, Parinya
    Simmons, Rebecca K.
    Hori, Hiroyuki
    Sharp, Stephen
    Khaw, Kay-Tee
    Wareham, Nicholas J.
    Griffin, Simon J.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2010, 60 (577): : e327 - e334
  • [44] ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management
    de Nijs, Tjerk
    Sniderman, Allan
    de Graaf, Jacqueline
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2013, 50 (06) : 163 - 171
  • [45] Non-HDL cholesterol contributes to the "hypertriglyceridemic waist" as a cardiovascular risk factor
    Bos, G
    Dekker, JM
    Heine, R
    DIABETES CARE, 2004, 27 (01) : 283 - 284
  • [46] Composition of non-HDL cholesterol and residual cardiovascular risk in secondary prevention
    Hansen, M. K.
    Olesen, K. K. W.
    Thrane, P. G.
    Gyldenkerne, C.
    Stoedkilde-Joergensen, N.
    Andersen, M. H.
    Maeng, M.
    Mortensen, M. B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [47] A Retrospective Analysis of Non-HDL Cholesterol: For Improved Cardiovascular Risk Assessment
    Khan, Sohail Rafi
    Mukhtar, Ana
    Ahmed, Altaf
    ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE, 2015, 20 (02): : 97 - 102
  • [48] Cardiovascular risk estimation in older persons: SCORE OP
    Cooney, Marie Therese
    Selmer, Randi
    Lindman, Anja
    Tverdal, Aage
    Menotti, Alessandro
    Thomsen, Troels
    DeBacker, Guy
    De Bacquer, Dirk
    Tell, Grethe S.
    Njolstad, Inger
    Graham, Ian M.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (10) : 1093 - 1103
  • [49] Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk
    Holewijn, S.
    den Heijer, M.
    Swinkels, D. W.
    Stalenhoef, A. F. H.
    de Graaf, J.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (06) : 567 - 577
  • [50] LIPOPROTEINS AND LIPID METABOLISM: HDL. HDL CHOLESTEROL EFFLUX IS NOT PREDICTIVE OF CARDIOVASCULAR RISK IN DIABETIC PATIENTS ON HEMODIALYSIS
    Kopecky, C.
    Ebtehaj, S.
    Genser, B.
    Wanner, C.
    Saemann, M. D.
    Tietge, U.
    ATHEROSCLEROSIS, 2016, 252 : E107 - E107
12345